Prajnan Das, MD, MS, MPH, FACR

Peer-Reviewed Articles

1. Harada K, Patnana M, Wang X, Iwatsuki M, Murphy MAB, Zhao M, Das P, Minsky BD, Weston B, Lee JH, Bhutani MS, Estrella JS, Shanbhag N, Ikoma N, Badgwell BD, Ajani JA. Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells. Surg Today 50(10):1223-1231, 2020. e-Pub 2020. PMID: 32409870.
2. Maroongroge S, Smith B, Bloom ES, Ning MS, Wang C, Das P, Koong AC, McAleer MF, Woodhouse KD. Telemedicine for Radiation Oncology in a Post-COVID World. Int J Radiat Oncol Biol Phys 108(2):407-410, 2020. PMID: 32890522.
3. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer 23(5):904-912, 2020. e-Pub 2020. PMID: 32347396.
4. Stark AP, Estrella JS, Chiang YJ, Das P, Minsky BD, Blum Murphy MA, Ajani JA, Mansfield P, Badgwell BD, Ikoma N. Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer. J Surg Oncol 122(3):422-432, 2020. e-Pub 2020. PMID: 32462681.
5. Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR, Minsky BD, Ludmir EB. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. Eur J Cancer 136:176-185, 2020. e-Pub 2020. PMID: 32702645.
6. Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32947844.
7. Blum Murphy M, Ikoma N, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Song S, Mansfield P, Ajani J, Badgwell B. Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology. Ann Surg Oncol 27(8):2806-2811, 2020. e-Pub 2020. PMID: 31974712.
8. Zafar SN, Blum M, Chiang YJ, Ajani JA, Estrella JS, Das P, Minsky BD, Hofstetter WL, Mansfield P, Badgwell BD, Ikoma N. Preoperative Chemoradiation versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma. Ann Thorac Surg 110(2):398-405, 2020. e-Pub 2020. PMID: 32289300.
9. Ning MS, McAleer MF, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Gunn GB, Klopp AH, Dabaja BS, Nguyen QN, Chronowski GM, Bloom ES, Koong AC, Das P. Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol 148:252-257, 2020. e-Pub 2020. PMID: 32474129.
10. Chang DT, Koay EJ, Herman JM, Hong TS, Das P. Abdominal and Pelvic Reirradiation for Recurrent Gastrointestinal Cancers. Semin Radiat Oncol 30(3):232-237, 2020. PMID: 32503788.
11. Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
12. Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, 2020. e-Pub 2020. PMID: 32775785.
13. Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 19(2):116-122, 2020. e-Pub 2020. PMID: 32173279.
14. Ikoma N, Agnes A, Chen HC, Wang X, Blum MM, Das P, Minsky B, Estrella JS, Mansfield P, Ajani JA, Badgwell BD. Linitis Plastica: a Distinct Type of Gastric Cancer. J Gastrointest Surg 24(5):1018-1025, 2020. e-Pub 2019. PMID: 31754987.
15. Moningi S, Ajani JA, Badgwell BD, Murphy MB, Ikoma N, Mansfield PF, Ho JC, Suh Y, Crane C, Herman JM, Holliday EB, Koay E, Koong AC, Krishnan S, Minsky B, Smith G, Taniguchi C, Das P. IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer. Adv Radiat Oncol 5(3):369-376, 2020. e-Pub 2019. PMID: 32529130.
16. Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P. Reporting and exclusion of sexual and gender minorities in cancer clinical trials. Int J Cancer 146(8):2360-2361, 2020. e-Pub 2019. PMID: 31584188.
17. Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P. Incidence and Correlates of HIV Exclusion Criteria in Cancer Clinical Trials. Int J Cancer 146(8):2362-2364, 2020. e-Pub 2019. PMID: 31746465.
18. Allen CJ, Vreeland TJ, Newhook TE, Das P, Minsky BD, Blum M, Ajani J, Ikoma N, Mansfield PF, Badgwell BD. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer. Ann Surg Oncol 27(2):534-542, 2020. e-Pub 2019. PMID: 31552618.
19. Dalwadi SM, Herman JM, Das P, Holliday EB. Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies. Hematol Oncol Clin North Am 34(1):29-43, 2020. e-Pub 2019. PMID: 31739949.
20. Allen CJ, Blumenthaler AN, Das P, Minsky BD, Blum M, Roy-Chowdhuri S, Ajani JA, Ikoma N, Mansfield PF, Badgwell BD. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. World J Surg Oncol 18(1):39, 2020. e-Pub 2020. PMID: 32066454.
21. Mizrak Kaya D, Nogueras González GM, Harada K, Blum Murphy MA, Lee JH, Bhutani MS, Weston B, Thomas I, Rogers JE, Das P, Badgwell BD, Ajani JA. Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma. Oncology 98(8):542-548, 2020. e-Pub 2020. PMID: 32434189.
22. Russo S, Anker CJ, Abdel-Wahab M, Azad N, Das P, Dragovic J, Goodman KA, Herman JM, Jones W, Kennedy T, Konski A, Kumar R, Lee P, Patel NM, Sharma N, Small W, Suh WW, Jabbour SK, Expert Panel on Radiation Oncology- Local Excision in Rectal Cancer. Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer. Int J Radiat Oncol Biol Phys 105(5):977-993, 2019. e-Pub 2019. PMID: 31445109.
23. Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky BD, Blum M, Song S, Ajani J, Ikoma N, Mansfield PF, Roy-Chowdhuri S, Badgwell BD. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer. J Surg Oncol 120(8):1350-1357, 2019. e-Pub 2019. PMID: 31612494.
24. Eng C, Jácome AA, Das P, Chang GJ, Rodriguez-Bigas M, Skibber JM, Wolff RA, Qiao W, Xing Y, Sethi S, Ohinata A, Crane CH. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal. Clin Colorectal Cancer 18(4):301-306, 2019. e-Pub 2019. PMID: 31350201.
25. Russo S, Anker CJ, Abdel-Wahab M, Azad N, Bianchi N, Das P, Dragovic J, Goodman KA, Jones W, Kennedy T, Kumar R, Lee P, Sharma N, Small W, Suh WW, Jabbour SK. Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer. Int J Radiat Oncol Biol Phys 105(3):591-605, 2019. e-Pub 2019. PMID: 31288054.
26. Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 19:59-65, 2019. e-Pub 2019. PMID: 31517071.
27. Stark AP, Ikoma N, Chiang YJ, Estrella JS, Das P, Minsky BD, Blum MM, Ajani JA, Mansfield P, Badgwell BD. Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy. Ann Surg Oncol 26(11):3602-3610, 2019. e-Pub 2019. PMID: 31350645.
28. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
29. George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer 125(16):2732-2746, 2019. e-Pub 2019. PMID: 31017664.
30. Choi GW, Suh Y, Das P, Herman J, Holliday E, Koay E, Koong AC, Krishnan S, Minsky BD, Smith GL, Taniguchi CM, Beddar S. Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration-based image guidance. Radiat Oncol 14(1):154, 2019. e-Pub 2019. PMID: 31470860.
31. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(7):855-883, 2019. PMID: 31319389.
32. Newhook TE, Agnes A, Blum M, Estrella JS, Das P, Ho L, Ajani JA, Minsky BD, Mansfield P, Badgwell BD. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Ann Surg Oncol 26(5):1394-1400, 2019. e-Pub 2019. PMID: 30680477.
33. Chadha AS, Gunther JR, Hsieh CE, Aliru M, Mahadevan LS, Venkatesulu BP, Crane CH, Das P, Herman JM, Koay EJ, Taniguchi C, Holliday EB, Minsky BD, Suh Y, Park P, Sawakuchi G, Beddar S, Odisio BC, Gupta S, Loyer E, Kaur H, Raghav K, Javle MM, Kaseb AO, Krishnan S. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol 133:54-61, 2019. e-Pub 2019. PMID: 30935582.
34. Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 24(23):5883-5894, 2018. e-Pub 2018. PMID: 30082477.
35. Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching. Gastric Cancer 21(6):1004-1013, 2018. e-Pub 2018. PMID: 29730720.
36. Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med 7(10):4880-4892, 2018. e-Pub 2018. PMID: 30152073.
37. Koay EJ, Owen D, Das P. Radiation-Induced Liver Disease and Modern Radiotherapy. Semin Radiat Oncol 28(4):321-331, 2018. PMID: 30309642.
38. Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol 3(4):595-600, 2018. e-Pub 2018. PMID: 30370360.
39. Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM. Dose escalation for locally advanced pancreatic cancer: How high can we go?. Adv Radiat Oncol 3(4):693-700, 2018. e-Pub 2018. PMID: 30370371.
40. Holliday EB, Lester SC, Harmsen WS, Eng C, Haddock MG, Krishnan S, Das P, Hallemeier CL. Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes. Int J Radiat Oncol Biol Phys 102(1):102-108, 2018. e-Pub 2018. PMID: 29907489.
41. Ikoma N, Estrella JS, Blum M, Das P, Chen HC, Wang X, Fournier K, Mansfield P, Ajani J, Badgwell BD. Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy. J Gastrointest Surg 22(8):1325-1333, 2018. e-Pub 2018. PMID: 29679346.
42. Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies. Radiat Oncol 13(1):143, 2018. e-Pub 2018. PMID: 30086784.
43. Golden DW, Kauffmann GE, McKillip RP, Farnan JM, Park YS, Schwartz A, Radiation Oncology Education Collaborative Study Group. Objective Evaluation of a Didactic Curriculum for the Radiation Oncology Medical Student Clerkship. Int J Radiat Oncol Biol Phys 101(5):1039-1045, 2018. e-Pub 2018. PMID: 29908787.
44. Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BD. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved. Ann Surg Oncol 25(7):2012-2017, 2018. e-Pub 2018. PMID: 29748883.
45. Mizrak Kaya D, Nogueras-Gonzáles GM, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Matamoros A, Devine CE, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma treated without surgery. Eur J Cancer 98:23-29, 2018. e-Pub 2018. PMID: 29859338.
46. Thiels CA, Ikoma N, Fournier K, Das P, Blum M, Estrella JS, Minsky BD, Ajani J, Mansfield P, Badgwell BD. Repeat staging laparoscopy for gastric cancer after preoperative therapy. J Surg Oncol 118(1):61-67, 2018. e-Pub 2018. PMID: 29878364.
47. Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD. The ypT category does not impact overall survival in node negative gastric cancer. J Surg Oncol 117(8):1721-1728, 2018. e-Pub 2018. PMID: 29949666.
48. Ikoma N, Cormier JN, Feig B, Du XL, Yamal J-M, Hofstetter W, Das P, Ajanai JA, Roland C, Fournier K, Royal R, Mansfield P, Badgwell BD. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of National Cancer Database 2006-2014. Cancer 124(5), 2018. PMID: 29393964.
49. Deshmukh AA, Zhao H, Franzini L, Lairson DR, Chiao EY, Das P, Swartz MD, Giordano SH, Cantor SB. Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States. Am J Clin Oncol 41(2):121-127, 2018. e-Pub 2015. PMID: 26523440.
50. Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol 41(7):632-637, 2018. e-Pub 2016. PMID: 27755060.
51. Deshmukh AA, Zhao H, Das P, Chiao EY, You YN, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB. Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer. Am J Clin Oncol 41(7):626-631, 2018. PMID: 27755059.
52. Badgwell B, Blum M, Das P, Estrella J, Wang X, Fournier K, Royal R, Mansfield P, Ajani J. Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer. Surg Endosc 32(1), 2018. e-Pub 2017. PMID: 28643069.
53. Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, Fournier KF, Mansfield P, Ajani JA, Badgwell BD. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer 32(1), 2018. e-Pub 2017. PMID: 28643144.
54. Mizrak Kaya D, Nogueras-González GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani MS, Matamoros A, Thomas I, Lin Q, Badgwell BD, Ajani JA. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J Surg Oncol 117(4):678-684, 2018. e-Pub 2017. PMID: 29205363.
55. Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer 124(8):1701-1709, 2018. PMID: 29370450.
56. Voong KR, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC, Wolff RA, Skibber JM, Feig BW, Chang GJ, Das P. Chemoradiation for High Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Am J Clin Oncol 40(6):555-560, 2017. e-Pub 2015. PMID: 26237193.
57. Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. PMID: 29299359.
58. Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg 152(11):1048-1056, 2017. PMID: 28700784.
59. Ikoma N, Das P, Blum M, Estrella JS, Devine CE, Wang X, Fournier K, Mansfield P, Minsky BD, Ajani J, Badgwell BD. Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer. Int J Radiat Oncol Biol Phys 99(3):660-666, 2017. e-Pub 2017. PMID: 29280460.
60. Badgwell B, Blum M, Das P, Estrella J, Wang X, Ho L, Fournier K, Royal R, Mansfield P, Ajani J. Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Ann Surg Oncol 24(11):3338-3344, 2017. e-Pub 2017. PMID: 28799004.
61. Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA. Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance. Oncotarget 8(46):81430-81440, 2017. e-Pub 2017. PMID: 29113402.
62. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Ann Surg Oncol 24(8):2291-2301, 2017. e-Pub 2016. PMID: 27770339.
63. Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 35(23):2631-2638, 2017. e-Pub 2017. PMID: 28657814.
64. Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MHG. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol 24(7):2031-2039, 2017. e-Pub 2017. PMID: 28124275.
65. Colbert LE, Moningi S, Chadha A, Amer A, Lee Y, Wolff RA, Varadhachary G, Fleming J, Katz M, Das P, Krishnan S, Koay EJ, Park P, Crane CH, Taniguchi CM. Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC. Adv Radiat Oncol 2(3):403-415, 2017. e-Pub 2017. PMID: 29114609.
66. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2(3):455-464, 2017. e-Pub 2017. PMID: 29114614.
67. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity among Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol 40(3):277-282, 2017. e-Pub 2016. PMID: 27028350.
68. Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 2017. e-Pub 2017. PMID: 29594206.
69. Sturgeon JD, Crane CH, Krishnan S, Minsky BD, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol 40(2):163-166, 2017. e-Pub 2014. PMID: 25222072.
70. Jones WE, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Small W, Herman JM, Expert Panel on Radiation OncologyGastrointestinal. ACR Appropriateness Criteria® Resectable Pancreatic Cancer. Am J Clin Oncol 40(2):109-117, 2017. PMID: 28230650.
71. Chadha AS, Liu G, Chen HC, Das P, Minsky BD, Mahmood U, Delclos ME, Suh Y, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH, Wang X, Thames H, Krishnan S. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?. Int J Radiat Oncol Biol Phys 97(2):323-332, 2017. e-Pub 2016. PMID: 28068240.
72. Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2016. PMID: 27778257.
73. Swanick CW, Allen PK, Tao R, Olanrewaju AM, Sutton JR, Lin SH, Welsh J, Das P, Chang JY, Crane CH, Gomez DR. Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions. Pract Radiat Oncol 7(1):63-71, 2017. e-Pub 2016. PMID: 27637136.
74. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol 122(1):146-151, 2017. e-Pub 2017. PMID: 28057329.
75. Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. 101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy. Oncology 93(4):243-248, 2017. e-Pub 2017. PMID: 28683449.
76. Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
77. Holliday EB, Swanick CW, McAvoy SA, Walker GV, Crane CH, Mahajan A, Das P. Development of a Comprehensive Clinical Radiation Oncology Resident Didactic Curriculum. J Am Coll Radiol 13(12 Pt A):1514-1516.e6, 2016. e-Pub 2016. PMID: 27554060.
78. Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. J Gastrointest Surg 20(12):1975-1985, 2016. e-Pub 2016. PMID: 27730398.
79. Ismael HN, Denbo J, Cox S, Crane CH, Das P, Krishnan S, Schroff RT, Javle M, Conrad C, Vauthey J, Aloia T. Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors. Eur J Surg Oncol 42(10):1591-6, 2016. e-Pub 2016. PMID: 27296729.
80. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14(10):1286-1312, 2016. PMID: 27697982.
81. Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, Shroff RT, Fogelman D, Overman M, Wang H, Maitra A, Lee JE, Fleming JB, Katz MH. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cancer 122(17):2671-9, 2016. e-Pub 2016. PMID: 27243381.
82. Valentini V, Gambacorta MA, Barbaro B, Chiloiro G, Coco C, Das P, Fanfani F, Joye I, Kachnic L, Maingon P, Marijnen C, Ngan S, Haustermans K. International consensus guidelines on Clinical Target Volume delineation in rectal cancer. Radiother Oncol 120(2):195-201, 2016. e-Pub 2016. PMID: 27528121.
83. Al-Shamsi HO, Fahmawi Y, Dahbour I, Tabash A, Rogers JE, Mares JE, Blum MA, Estrella J, Matamoros A, Sagebiel T, Devine CE, Badgwell BD, Lin QD, Das P, Ajani JA. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience. J Gastrointest Oncol 7(4):499-505, 2016. PMID: 27563438.
84. Expert Panel on Radiation Oncology-Gastrointestinal, Small W, Hayes JP, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Herman JM. ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer. Oncology (Williston Park) 30(7):619-24, 627, 632, 2016. PMID: 27422109.
85. Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA. Evolution of gastric surgery techniques and outcomes. Chin J Cancer 35(1):69, 2016. e-Pub 2016. PMID: 27460019.
86. Badgwell B, Blum M, Elimova E, Estrella J, Chiang YJ, Das P, Mansfield P, Ajani J. Frequency of Resection after Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma. Ann Surg Oncol 23(6):1948-1955, 2016. e-Pub 2016. PMID: 26868957.
87. Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-based Peer-review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract 12(4):e476-486, 2016. e-Pub 2016. PMID: 26931402.
88. Krishnan S, Chadha AS, Suh Y, Chen HC, Rao A, Das P, Minsky BD, Mahmood U, Delclos ME, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation. Int J Radiat Oncol Biol Phys 94(4):755-765, 2016. e-Pub 2015. PMID: 26972648.
89. Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell B. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?. Ann Surg Oncol 23(2):626-632, 2016. e-Pub 2015. PMID: 26564243.
90. Radiation Oncology Education Collaborative Study Group, Radiation Oncology Education Collaborative Study Group Writing Committee:, Golden DW, Braunstein S, Jimenez RB, Mohindra P, Spektor A, Ye JC, Radiation Oncology Education Collaborative Study Group Members:, Bradley KA, Chmura SJ, Currey A, Das P, Du K, Haas-Kogan D, Howard AR, Higgins SA, Hung AY, Kharofa J, Krishnan MS, MacDonald SM, Mancini BR, Parashar B, Thaker NG, Thomas CR, Viswanathan AN, Wheatley M. Multi-institutional implementation and evaluation of a curriculum for the medical student clerkship in radiation oncology. J Am Coll Radiol 13(2):203-209, 2016. PMID: 26410347.
91. Badgwell B, Ajani J, Blum M, Ho L, Fournier K, Chiang YJ, Matamoros A, Das P, Mansfield P. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy. Ann Surg Oncol 23(1):156-162, 2016. e-Pub 2015. PMID: 26059652.
92. Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis. J Clin Oncol 34(3):219-226, 2016. e-Pub 2015. PMID: 26503201.
93. Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol 113(1):29-35, 2016. e-Pub 2015. PMID: 26603684.
94. Charalampakis N, Nogueras González GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Matamoros A, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA. The proportion of signet ring cell component in patients with localized gastric adenocarcinoma correlates with the degree of response to preoperative chemoradiation. Oncology 90(5):239-247, 2016. e-Pub 2016. PMID: 27046280.
95. Gunther JR, Liauw SL, Choi S, Mohamed AS, Thaker NG, Fuller CD, Stepaniak CL, Das P, Golden DW. A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation. J Am Coll Radiol 13(7):835-841, 2016.
96. You YN, Skibber JM, Hu CY, Crane CH, Das P, Kopetz ES, Eng C, Feig BW, Rodriguez-Bigas MA, Chang GJ. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg 103(6):753-762, 2016. PMID: 26933792.
97. Chadha AS, Skinner HD, Gunther JR, Munsell MF, Das P, Minsky BD, Delclos ME, Chatterjee D, Wang H, Clemons M, George G, Singh PK, Katz MH, Fleming JB, Javle MM, Wolff RA, Varadhachary GR, Crane CH, Krishnan S. Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One 11(6):e0156910, 2016. e-Pub 2016. PMID: 27336466.
98. Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors. Oncology 91(1):55-60, 2016. e-Pub 2016. PMID: 27120436.
99. Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex with Men. Clin Infect Dis 61(10):1527-1535, 2015. e-Pub 2015. PMID: 26223993.
100. Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang G, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist 20(11):1247-1252, 2015. e-Pub 2015. PMID: 26382740.
101. Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology 89(6):305-310, 2015. e-Pub 2015. PMID: 26393501.
102. Russo S, Blackstock AW, Herman JM, Abdel-Wahab M, Azad N, Das P, Goodman KA, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol 38(5):520-5, 2015. PMID: 26371522.
103. Hui C, Suh Y, Robertson D, Pan T, Das P, Crane CH, Beddar S. Internal respiratory surrogate in multi-slice 4D CT using a combination of Fourier transform and anatomical features. Med Phys 42(7):4338, 2015. PMID: 26133631.
104. Badgwell B, Blum M, Estrella J, Chiang YJ, Das P, Matamoros A, Fournier K, Mansfield P, Ajani J. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy. J Am Coll Surg 221(1):83-90, 2015. e-Pub 2015. PMID: 26002780.
105. Tang Y, Crane C, Eng C, Minsky BD, Delclos ME, Krishnan S, Malatek D, Gould MS, Das P. Quality of life after intensity-modulated radiation therapy for anal cancer. J Radiat Oncol 4(3):291-298, 2015. e-Pub 2015.
106. Ye JC, Mohindra P, Spektor A, Krishnan MS, Chmura SJ, Howard AR, Viswanathan AN, MacDonald SM, Thaker NG, Das P, Mancini BR, Higgins SA, Braunstein S, Haas-Kogan D, Bradley KA, Hung AY, Thomas CR, Kharofa J, Wheatley M, Currey A, Parashar B, Du K, Jimenez RB, Golden DW. Medical Student Perspectives on a Multi-institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. Int J Radiat Oncol Biol Phys 92(2):217-219, 2015. PMID: 25968822.
107. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 13(2):194-227, 2015. PMID: 25691612.
108. Walker GV, Johnson J, Edwards T, Gatilao RA, Hayden SE, Riley BA, Sittig DF, Gillin M, Ibbott G, Buchholz TA, Das P. Factors associated with radiation therapy incidents in a large academic institution. Pract Radiat Oncol 5(1):21-27, 2015. e-Pub 2014. PMID: 25413430.
109. Chadha AS, Kocak-Uzel E, Das P, Minsky BD, Delclos ME, Mahmood U, Guha S, Ahmad M, Varadhachary GR, Javle M, Katz MH, Fleming JB, Wolff RA, Crane CH, Krishnan S. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncol 54(7):971-978, 2015. PMID: 25608822.
110. Elimova E, Wadhwa R, Shiozaki H, Sudo K, Estrella JS, Badgwell BD, Das P, Matamoros A, Song S, Ajani JA. Molecular Biomarkers in Gastric Cancer. J Natl Compr Canc Netw 13(4):e19-e29, 2015.
111. Elimova E, Shiozaki H, Slack RS, Chen HC, Wadhwa R, Sudo K, Charalampakis N, Hiremath A, Estrella JS, Matamoros A, Sagebiel T, Das P, Rogers JE, Garris JL, Blum MA, Badgwell B, Ajani JA. Early versus Delayed Therapy of Advanced Gastric Cancer Patients - Does It Make a Difference?. Oncology 89(4):215-20, 2015. e-Pub 2015. PMID: 26159599.
112. Pujara D, Mansfield P, Ajani J, Blum M, Elimova E, Chiang YJ, Das P, Badgwell B. Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy. J Surg Oncol 112(8):883-887, 2015. e-Pub 2015. PMID: 26482869.
113. Daroui P, Jabbour SK, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Hong TS, Jones WE 3rd, Kaur H, Konski AA, Koong AC, Kumar R, Pawlik TM, Small W Jr, Thomas CR Jr, Suh WW. ACR Appropriateness Criteria Resectable Stomach Cancer. Oncology 29(8):595-602, 2015.
114. Deshmukh AA, Chiao EY, Das P, Cantor SB. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia. Vaccine 32(51):6941-6947, 2014. e-Pub 2014. PMID: 25444820.
115. Eng C, Chang GJ, You YN, Das P, Rodriguez-Bigas M, Xing Y, Vauthey JN, Rogers JE, Ohinata A, Pathak P, Sethi S, Phillips JK, Crane CH, Wolff RA. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget 5(22):11133-11142, 2014. e-Pub 2014. PMID: 25373735.
116. Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P. Intensity-Modulated Radiation Therapy with Concurrent Chemotherapy for Anal Cancer: Outcomes and Toxicity. Am J Clin Oncol 37(5):461-466, 2014. e-Pub 2013. PMID: 23466576.
117. Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK. Low-dose chest computed tomography for lung cancer screening among hodgkin lymphoma survivors: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys 90(2):344-353, 2014. e-Pub 2014. PMID: 25104066.
118. Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, Estrella JS, Blum MA, Badgwell B, Das P, Song S, Ajani JA. Medical management of gastric cancer: A 2014 update. World J Gastroenterol 20(38):13637-13647, 2014. PMID: 25320502.
119. Goodman KA, Milgrom SA, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Rectal Cancer: Metastatic Disease at Presentation. Oncology (Williston Park) 28(10), 2014. PMID: 25323613.
120. Hodges JC, Beg MS, Das P, Meyer J. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Anal Cancer. Int J Radiat Oncol Biol Phys 89(4):773-783, 2014. e-Pub 2014. PMID: 24726392.
121. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol 109(7):652-658, 2014. e-Pub 2014. PMID: 24510523.
122. Rogers JE, Crane CH, Das P, Delclos M, Gould MS, Ohinata A, Malatek D, Eng C. Definitive chemoradiation in oligometastatic squamous cell carcinoma of the anal canal. Gastrointest Cancer Res 7(2):65-68, 2014. PMID: 24799976.
123. Das P, Eng C, Rodriguez-Bigas M, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial. Int J Radiat Oncol Biol Phys 88(2):301-305, 2014. PMID: 24315563.
124. Hong TS, Pretz JL, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Jabbour SK, Jones WE 3rd, Konski AA, Koong AC, Rodriguez-Bigas M, Small W Jr, Thomas CR Jr, Zook J, Suh WW. ACR Appropriateness Criteria-Anal Cancer. Gastrointest Cancer Res 7(1):4-14, 2014.
125. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-4241, 2013. e-Pub 2013. PMID: 24089344.
126. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-3775, 2013. e-Pub 2013. PMID: 24037775.
127. Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric Bleeding After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Pract Radiat Oncol 3(4):344-348, 2013. e-Pub 2012. PMID: 24674408.
128. Das P, Minsky BD. A Watch-and-Wait Approach to the Management of Rectal Cancer. Oncology (Williston Park) 27(10):962-968, 2013. PMID: 24367851.
129. Das P, Johnson J, Hayden SE, Riley BA, Harrelson S, Gillin M, Ibbott G, Buchholz TA. Rate of radiation therapy events in a large academic institution. J Am Coll Radiol 10(6):452-455, 2013. PMID: 23735271.
130. Albert JM, Das P. Quality Indicators in Radiation Oncology. Int J Radiat Oncol Biol Phys 85(4):904-911, 2013. e-Pub 2012. PMID: 23040217.
131. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal Toxicity after Fractionated Chemoradiation for Unresectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys 85(3):e143-149, 2013. e-Pub 2012. PMID: 23200173.
132. Guadagnolo BA, Huo J, Liao KP, Buchholz TA, Das P. Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States. Cancer 119(5):1089-1097, 2013. e-Pub 2012. PMID: 23132206.
133. Mirnezami R, Chang GJ, Das P, Chandrakumaran K, Tekkis P, Darzi A, Mirnezami AH. Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol 22(1):22-35, 2013. e-Pub 2012. PMID: 23270946.
134. Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):1109-1014, 2013.
135. Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Kelly P, Sandulache VC, Delclos ME, Krishnan S, Das P. Metformin use and improved response to therapy in rectal cancer. Cancer Med 2(1):99-107, 2013.
136. Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98(1):192-197, 2013.
137. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11(5):531-546, 2013.
138. Briere TM, Crane CH, Beddar S, Bhosale P, Mok H, Delclos ME, Krishnan S, Das P. Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients. Radiother Oncol 104(2):161-166, 2012. e-Pub 2012. PMID: 22841019.
139. Schoenfeld JD, Mauch PM, Das P, Silver B, Marcus KJ, Stevenson MA, Ng AK. Lung malignancies after Hodgkin lymphoma: Disease characteristics, detection methods and clinical outcome. Ann Oncol 23(7):1813-8, 2012. e-Pub 2011. PMID: 22104573.
140. Albert JM, Das P. Quality assessment in oncology. Int J Radiat Oncol Biol Phys 83(3):773-781, 2012. e-Pub 2012. PMID: 22445001.
141. Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P. Intensity Modulated Radiation Therapy with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. Int J Radiat Oncol Biol Phys 83(2):581-586, 2012. e-Pub 2011. PMID: 22137021.
142. Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ. Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer. J Clin Oncol 30(15):1770-1776, 2012. e-Pub 2012. PMID: 22493423.
143. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of Definitive Radiation Therapy in Carcinoma of Unknown Primary in the Abdomen and Pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-2017, 2012. e-Pub 2011. PMID: 21640510.
144. Jones WE 3rd, Thomas CR Jr, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W Jr, Zook J, Suh WW. ACR Appropriateness Criteria  Resectable Rectal Cancer. Radiat Oncol 7:161, 2012.
145. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-351, 2012.
146. Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey JN, Abdalla EK, Delclos ME, Das P, Crane CH, Krishnan S. Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 50(8):1191-1198, 2011. e-Pub 2011. PMID: 21793641.
147. Tan CH, Bhosale PR, Das P, Crane CH, Viswanathan C, Raval B, Eng C, Iyer RB. Multidetector Computed Tomography Follow-up of Hypoattenuating Small Liver Lesions in Patients With Rectal Cancer. Am J Clin Oncol 34(4):411-416, 2011. PMID: 20686401.
148. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713-3722, 2011. e-Pub 2011. PMID: 21328329.
149. Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression. J Clin Oncol 29(22):3037-3043, 2011. e-Pub 2011. PMID: 21709185.
150. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 9(8):830-887, 2011. PMID: 21900218.
151. Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of Preoperative Radiation Therapy for Rectal Cancer From 2000 to 2006: A Surveillance, Epidemiology, and End Results Patterns-of-Care Study. Int J Radiat Oncol Biol Phys 80(4):978-984, 2011. e-Pub 2010. PMID: 20961695.
152. Mok H, Briere TM, Martel MK, Beddar S, Delclos ME, Krishnan S, Crane CH, Das P. Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma. Prac Radiat Oncol 1(3):163-172, 2011.
153. Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. J Am Coll Radiol 8(5):302-308, 2011. PMID: 21531305.
154. Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's Lymphoma in Young Female Patients: A New Technique to Avoid the Breasts and Decrease the Dose to the Heart. Int J Radiat Oncol Biol Phys 79(2):503-507, 2011. e-Pub 2010. PMID: 20418023.
155. Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, Krishnan S, Das P. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol 6(63), 2011.
156. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer. Ann Surg Oncol 17(11):2863-2869, 2010. e-Pub 2010. PMID: 20552409.
157. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W, Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835-844, 2010. e-Pub 2010. PMID: 20692872.
158. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated Accelerated Radiotherapy for Rectal Cancer in Patients with Prior Pelvic Irradiation. Int J Radiat Oncol Biol Phys 77(1):60-65, 2010. e-Pub 2009. PMID: 19695792.
159. Ajani JA, Wang X, Izzo JG, Crane CH, Eng C, Skibber JM, Das P, Rashid A. Molecular Biomarkers Correlate with Disease-Free Survival in Patients with Anal Canal Carcinoma Treated with Chemoradiation. Dig Dis Sci 55(4):1098-1105, 2010. e-Pub 2009. PMID: 19399614.
160. Das P, Jiang Y, Lee JH, Bhutani MS, Ross WA, Mansfield PF, Ajani JA. Multimodality Approaches to Localized Gastric Cancer. J Natl Compr Canc Netw 8(4):417-425, 2010. PMID: 20410334.
161. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G. Gastric cancer. J Natl Compr Canc Netw 8(4):378-409, 2010. PMID: 20410333.
162. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 76(3):824-830, 2010. e-Pub 2009. PMID: 19464823.
163. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH. Long-Term Quality of Life after Radiation Therapy for Treatment of Anal Cancer. Cancer 116(4):822-829, 2010. e-Pub 2009. PMID: 20041481.
164. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical Significance of Acellular Mucin in Rectal Adenocarcinoma Patients With a Pathologic Complete Response to Preoperative Chemoradiation. Ann Surg 251(2):261-264, 2010. PMID: 19864936.
165. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer. Ann Surg Oncol 17(2):441-447, 2010. e-Pub 2009. PMID: 19847569.
166. Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer 34:211-227, 2010.
167. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity-Modulated Radiation Therapy for the Treatment of Squamous Cell Anal Cancer with Para-Aortic Nodal Involvement. Int J Radiat Oncol Biol Phys 75(3):791-794, 2009. e-Pub 2009. PMID: 19231109.
168. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, Zhang Y, Delclos ME, Crane CH, Das P, Wang XS, Cleeland CS, Krishnan S. Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated with Preoperative Chemoradiation Therapy for Rectal Cancer. Int J Radiat Oncol Biol Phys 75(3):775-781, 2009. e-Pub 2009. PMID: 19231100.
169. Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P. Sacral Insufficiency Fractures After Preoperative Chemoradiation for Rectal Cancer: Incidence, Risk Factors, and Clinical Course. Int J Radiat Oncol Biol Phys 74:818-823, 2009. PMID: 19147305.
170. Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA. A Twenty-year Experience with Adenocarcinoma of the Anal Canal. Dis Colon Rectum 52:1375-1380, 2009. PMID: 19617747.
171. Haque W, Crane CH, Krishnan S, Delclos ME, Javle M, Garrett CR, Wolff RA, Das P. Reirradiation to the abdomen for gastrointestinal malignancies. Radiat Oncol 4:55, 2009. PMID: 19922641.
172. Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of Vater. Int J Radiat Oncol Biol Phys 70(3):735-743, 2008. e-Pub 2008. PMID: 17980502.
173. Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S. Clinical benefit of palliative radiation therapy in advanced gastric cancer. Acta Oncol 47(3):421-427, 2008. e-Pub 2007. PMID: 17899453.
174. Yu T-K, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 71(4):1175-1180, 2008. e-Pub 2008. PMID: 18207667.
175. Das P, Crane CH, Eng C, Ajani JA. Prognostic factors for squamous cell cancer of the anal canal. Gastrointest Cancer Res 2(1):1-14, 2008. PMID: 19259318.
176. Reed VK, Krishnan S, Mansfield PF, Bhosale PR, Kim M, Das P, Janjan NA, Delclos ME, Lowy AM, Feig BW, Pisters PW, Ajani JA, Crane CH. Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71(3):741-747, 2008. e-Pub 2007. PMID: 18164837.
177. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthery JN. Extrahepatic bile duct adenocarcinoma: Patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 15(11):3147-3156, 2008. e-Pub 2008. PMID: 18754070.
178. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee J, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3487-3495, 2008. PMID: 18640929.
179. Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S. Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. Int J Radiat Oncol Biol Phys 71(1):167-172, 2008. PMID: 18406886.
180. Das P, Ng A, Constine LS, Hodgson DC, Mendenhall NP, Morris DE, Yunes MJ, Chauvenet AR, Hudson MM, Winter JN. ACR Appropriateness Criteria on Hodgkin's lymphoma - Favorable prognosis stage I and II. J Am Coll Radiol 5:1054-1066, 2008.
181. Myerson RJ, Garofalo MC, Naga IE, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: An Radiation Therapy Oncology Group Consensus Panel Contouring Atlas. Int J Radiat Oncol Biol Phys 74:824-830, 2008. PMID: 19117696.
182. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Biol Phys 68:794-800, 2007.
183. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients treated with preoperative chemoradiation for rectal cancer. Cancer 109:1750-1755, 2007.
184. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Gastrointest Cancer Res 1:44-48, 2007.
185. Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 110:47-55, 2007.
186. Beddar AS, Krishnan S, Briere TM, Wang X, Delclos ME, Ballo MT, Das P, Gould S, Horton JL, Crane CH. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators. Radiother Oncol 78:207-212, 2006. PMID: 16376445.
187. Das P, Fukami N, Ajani JA. Combined modality therapy of localized gastric and esophageal cancers. J Natl Compr Canc Netw 4:375-382, 2006. PMID: 16569390.
188. Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 17:785-793, 2006. PMID: 16500905.
189. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 66:1378-1383, 2006. PMID: 17056196.
190. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29:219-224, 2006. PMID: 16755173.
191. Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH. Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. Radiat Oncol 1:41, 2006. PMID: 17062148.
192. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66:762-771, 2006. PMID: 17011451.
193. Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, Das P, Delclos ME, Janjan NA, Crane CH. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol 29:562-567, 2006. PMID: 17148992.
194. Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107:2589-2596, 2006. PMID: 17083124.
195. Das P, Ajani JA. Gastric and gastro-oesophageal cancer therapy. Expert Opin Pharmacother 6:2805-2812, 2005. PMID: 16318431.
196. Das P, Ng AK, Stevenson MA, Mauch PM. Clinical course of thoracic cancers in Hodgkin's disease survivors. Ann Oncol 16:793-797, 2005. PMID: 15802277.
197. Das P, Chen MH, Valentine K, Lopes L, Cormack RA, Renshaw AA, Tempany CM, Kumar S, D'Amico AV. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys 54:698-702, 2002. PMID: 12377320.
198. Das P, Kaplan I. The role of PC-SPES, selenium, and vitamin E in prostate cancer. Oncology (Williston Park) 16:285-291; discussion 291, 295-296, 299-300, 2002. PMID: 15046388.
199. Smith R, Trindade MC, Ikenoue T, Mohtai M, Das P, Carter DR, Goodman SB, Schurman DJ. Effects of shear stress on articular chondrocyte metabolism. Biorheology 37:95-107, 2000. PMID: 10912182.
200. Kim WK, Choi YB, Rayudu PV, Das P, Asaad W, Arnelle DR, Stamler JS, Lipton SA. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24:461-469, 1999. PMID: 10571239.
201. Das P, Schurman DJ, Smith RL. Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear. J Orthop Res 15:87-93, 1997. PMID: 9066531.
202. Pullin JG, Collier MA, Das P, Smith RL, DeBault LE, Johnson LL, Walls RC. Effects of Holmium-YAG laser energy on cartilage metabolism, healing, and biochemical properties of lesional and perilesional tissue in a weight-bearing model. Arthroscopy 12:15-25, 1996. PMID: 8838724.
203. Smith RL, Donlon BS, Gupta MK, Mohtai M, Das P, Carter DR, Cooke J, Gibbons G, Hutchinson N, Schurman DJ. Effects of fluid-induced shear on articular chondrocyte morphology and metabolism in vitro. J Orthop Res 13:824-831, 1995. PMID: 8544017.
204. Badgwell B, Ikoma N, Murphy MB, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Lano E, Song S, Mansfield P, Ajani J. A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Ann Surg Oncol. e-Pub 2020. PMID: 32556731.
205. Ikoma N, Estrella JS, Blum Murphy M, Das P, Minsky BD, Mansfield P, Ajani JA, Badgwell BD. Tumor Regression Grade in Gastric Cancer After Preoperative Therapy. J Gastrointest Surg. e-Pub 2020. PMID: 32542556.
206. Mesko S, Chapman BV, Tang C, Kudchadker RJ, Bruno TL, Sanders J, Das P, Pinnix CC, Thaker NG, Frank SJ. Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents. Brachytherapy. e-Pub 2020. PMID: 32952054.
207. Kouzy R, Abi Jaoude J, Minsky BD, Das P, Koong AC, Subbiah IM, Ludmir EB, Taniguchi CM. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. BMJ Support Palliat Care. e-Pub 2020. PMID: 32943466.
208. Blumenthaler AN, Ikoma N, Blum M, Das P, Minsky BD, Mansfield PF, Ajani JA, Badgwell BD. Relationship between initial management strategy and survival in patients with gastric outlet obstruction due to gastric cancer. J Surg Oncol. e-Pub 2020. PMID: 32810292.
209. Blumenthaler AN, Allen CJ, Ikoma N, Blum M, Das P, Minsky BD, Mansfield PF, Ajani JA, Badgwell BD. Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Ann Surg Oncol. e-Pub 2020. PMID: 32737700.
210. Noticewala SS, Ludmir EB, Eng C, Holliday EB, Minsky BD, Morris VK, Das P. Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al. Radiother Oncol 151:56-57. e-Pub 2020. PMID: 32710989.
211. Allen CJ, Blumenthaler AN, Smith GL, Das P, Minsky BD, Blum M, Ajani J, Mansfield PF, Ikoma N, Badgwell BD. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience. Ann Surg Oncol. e-Pub 2020. PMID: 32696305.
212. Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. JCO Oncol Pract:OP2000122. e-Pub 2020. PMID: 32609585.

Invited Articles

1. Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 10(1):149, 2017. e-Pub 2017. PMID: 28810883.
2. Elimova E, Wadhwa R, Estrella JS, Sudo K, Shiozaki H, Blum MA, Chen Q, Song S, Das P, Ajani JA. Anal canal cancer: biology and therapy. Expert Opin Orphan Drugs 2(2), 2014.
3. Cox JA, Crane CH, Das P. Do We Need Intensity Modulated Radiation Therapy (IMRT) Routinely in the Preoperative Setting for Rectal Cancer?. Curr Colorectal Cancer Rep 8(2):99-104, 2012.
4. Tsai CJ, Das P. Impact of PET/CT-Based Radiation Therapy Planning in Gastrointestinal Malignancies. PET Clinics 6:185-193, 2011.
5. Das P, Crane CH. Predictors of Outcome for Anal Cancer. Radiat Med Rounds 1:391-398, 2010.
6. Das P, Crane CH. Staging, Prognostic Factors and Therapy of Localized Rectal Cancer. Curr Oncol Rep 11(3):167-174, 2009. PMID: 19336008.
7. Das P. Preoperative Chemoradiotherapy for Stage III Rectal Cancer. Gastrointest Cancer Res 2(6):302-304, 2008. PMID: 19259282.
8. Das P, Crane CH, Ajani JA. Current treatment for localized anal carcinoma. Curr Opin Oncol 19:396-400, 2007.
9. Crane CH, Das P. Potential benefits of integration of targeted therapies with chemoradiation in rectal cancer. Gastrointest Cancer Res 1:S77-S84, 2007.
10. Das P, Crane CH. Preoperative and adjuvant treatment of localized rectal cancer. Curr Oncol Rep 8:167-173, 2006. PMID: 16618380.

Manuals, Teaching Aids, Other Teaching Publications

1. Reed VK, Das P. Stomach cancer. BMJ Point of Care, 2008.

Other Articles

1. Gunther J, Liauw S, Choi S, Stepaniak C, Das P, Golden D Post-Operative Prostate and Seminal Vesicle Fossae Contouring Module: Evaluation of Medical Student Target Delineation Before and After a Teaching Intervention. MedEdPORTAL Pub, 2015.
2. Elimova E, Badgwell B, Das P, Estrella J, Matamoros A, Ajani JA How Do We Treat Patients with Gastric Cancer?. Oncology Times 36(16):11-12, 2014.
3. Das P Book Review - Rectal Cancer: International Perspectives on Multimodality Management. Int J Radiat Oncol Biol Phys 79:1277, 2011.

Editorials

1. Wu AJ, Vapiwala N, Chmura SJ, Das P, Decker RH, Terezakis SA, Zietman AL. Taking "the Game" Out of The Match: A Simple Proposal. Int J Radiat Oncol Biol Phys 93(5):945-8, 2015. PMID: 26581129.
2. Das P. Rectal cancer: Do protons have prospects?. J Gastrointest Oncol 5(1):1-2, 2014. PMID: 24490036.
3. Das P, Strong VE, Ajani JA. Adjuvant and neoadjuvant therapy for gastric cancer: taking stock of the options. Gastrointest Cancer Res 5(6):203-204, 2012.
4. Das P. Esophageal cancer: Is preoperative chemoradiation the new standard?. J Gastrointest Oncol 1:68-69.

Abstracts

1. Ikoma N, Estrella J, Das P, Minsky BD, Fournier KF, Mansfield PF, Blum MA, Ajani JA, Badgwell BD. Tumor regression grade in gastric cancer after preoperative therapy. J Clin Oncol 37(S4):Abstr 168, 2019.
2. Moningi S, Ajani JA, Badgwell BD, Mansfield PF, Blum Murphy MA, Ikoma N, Ho J, Suh Y, Holliday EB, Herman JM, Minsky BD, Koay EJ, Koong A, Krishnan S, Smith GL, Taniguchi CM, Das P. The effect of IMRT on acute toxicity in patients with gastric cancer treated with preoperative chemoradiation. J Clin Oncol 37(4S):Abstr 153, 2019.
3. Kaya DM, Nogueras-Gonzalez GM, Das P, Blum Murphy MA, Amlashi FG, Rogers JE, Thomas I, Shanbhag N, Lee JH, Bhutani MS, Weston B, Minsky BD, Matamoros A, Sagebiel TL, Devine CE, Estrella J, Badgwell B, Ajani JA. Efficacy of three-drug induction chemotherapy followed by preoperative chemoradiation in patients with localized gastric adenocarcinoma. J Clin Oncol 37(4S):Abstr 106, 2019.
4. You YN, George TJ, Chaing Y-J, Eng C, Das P, Chang GJ, Dasari A, Cuddy A, Yang Y, Yothers G. Validation Of Neoadjuvant Rectal Cancer (NAR) Score As A Surrogate Endpoint For Overall Survival In Real-life Practice Settings. J Clin Oncol 36(S):Abstr 3517, 2018.
5. Ikoma N, Estrella J, Hofstetter WL, Das P, Ajani JA, Fournier KF, Mansfield PF, Badgwell BD. Nodal downstaging in gastric cancer in relation to survival when ypN0 is achieved. J Clin Oncol 36(4S):Abstr 93, 2018.
6. Colber LE, Lin D, Minsky BD, Holliday EB, Klopp A, Das P, Eng C, Morris VK, Taniguchi CM. A prospective biomarker trial of microbiome, immune, and genomic markers as predictors of radiation response in anal squamous cell carcinoma. J Clin Oncol 36(4S):Abstr TPS869, 2018.
7. Hester RH, Taniguchi CM, Holliday EB, Koay EJ, Das P, Minsky BD, Rashid A, Mehdizdadeh A, Ohinata A, Messick C, Yoy YN, Chang GJ, Bednarski B, Rodriguez-Bigas MA, Skibber JM, WOlff RA, Eng C, Morris VK. CEA as a pharmacodynamic biomarker for metastatic anal cancer. J Clin Oncol 36(4S):Abstr 684, 2018.
8. Potentially curable gastric adenocarcinoma (GAC) patients treated without surgery. Potentially curable gastric adenocarcinoma (GAC) patients treated without surgery. J Clin Oncol 36(4S):Abstr 120, 2018.
9. Ng SP, Liu A, Tao R, Holliday EB, Brownlee Z, Kaseb AO, Raghav KPS, Vauthey J-N, Minsky BD, Herman JM, Das P, Taniguchi CM, Krishnan S, Crane CH, Hong TS, Mohan R, Koay EJ. Lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy. J Clin Oncol 36(4S):Abstr 278, 2018.
10. Sammour T, Malakorn S, Chang GJ, Rodriguez-Bigas MA, Bednarski B, Eng C, Das P, Skibber JM, You YN. Longitudinal trajectory of cancer survivorship in patients with recurrent rectal cancer: Anatomy of recurrence in relation to quality of life and pain. J Clin Oncol 35(4S):Abstract 679, 2017.
11. Mizrak Kaya D, Nogueras-Gonzalez GM, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella J, Lin Q, Amlashi GA, Lee JH, Weston B, Bhutani MS, Wu CC, Matamoros A, Sagebiel TL, Mansfield PF, Badgwell BD, Ajani JA. Risk of peritoneal carcinomatosis in localized gastric adenocarcinoma patients who undergo preoperative therapy and attempted surgery. J Clin Oncol 35(4S):Abstract 104, 2017.
12. Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella J, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A, Sagebiel TL, Skinner HD, Wu CC, Hofstetter WL, Badgwell BD, Ajani JA. Long-term survival in 101 metastatic gastroesophageal cancer (mGEAC) patients eventually treated with consolidative local therapy. J Clin Oncol 35(4S):Abstract 197, 2017.
13. Lu Y, Tang C, Liao Z, Jeter M, Hahn S, Das P, Koay E, Herman J, Nguyen Q-N. Long-Term Outcome and Toxicity of Stereotactic Ablative Body Radiotherapy (SABR) for Liver Metastases From Solid Tumors. Int J Radiat Oncol Biol Phys 98(2S):E14, 2017.
14. Moningi S, Amer A, Colbert L, Lee Y, Wolff R, Varadhachary G, Das P, Herman JH, Taniguchi C, Fleming JB, Katz MH, Crane C, Le O, Bhosale P, Tamm E, Koay EJ. Can Imaging-Based Biomarkers of Pancreatic Cancer be Used to Select Patients for Dose-Escalated Radiotherapy?. Int J Radiat Oncol Biol Phys 98(2S):E7, 2017.
15. Gunther JR, Chadha AS, Yang P, Munsell MF, Das P, Delclos ME, Foo WC, Kaur H, Clemons M, Mathew GG, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Bhutani M, Raju GS, Eng C, Guha S, Krishnan S. A Phase 2 Randomized Double Blinded Study Evaluating the Efficacy of Curcumin With Pre-Operative Chemoradiation for Rectal Cancer. Int J Radiat Oncol Biol Phys 98(2S):E7, 2017.
16. Tao R, Tsai CJ, Eng C, Kopetz S, Overman M, Skibber J, Rodriguez-Bigas M, Chang G, You YN, Bednarski B, Minsky BD, Delclos ME, Koay EJ, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Rectal Cancer: A Large Single Institution Retrospective Analysis. Int J Radiat Oncol Biol Phys 96(2S):Abstract 236, 2016.
17. Shin US, You YN, Price BA, Rodriguez-Bigas MA, Skibber JM, Maru DM, Taggart MW, Kopetz S, Eng C, Minsky BD, Das P, Krishnan S, Chang GJ. Is the neutrophil-lymphocyte ratio (NLR) a predictive and prognostic factor in rectal cancer patients treated with neoadjuvant chemoradiation?. J Clin Oncol 34:Abstr 3605, 2016.
18. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Shiozaki H, Minsky BD, Das P, Hofstetter WL, Swisher S, Skiner HD, Maru DM, Matamoros A, Blum M, Lee JH, Weston B, Bhutani MS, Mansfield PF, Badgwell BD, Ajani JA. Outcomes in older patients with localized gastric adenocarcinoma treated preoperatively. J Clin Oncol 34:Abstr 4029, 2016.
19. Badgwell BD, Blum MA, Das P, Elimova E, Mansfield PF, Ajani JA. A phase II study of laparoscopic hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric carcinomatosis or positive cytology. J Clin Oncol 34(suppl 4S):Abstr TPS186, 2016.
20. Charalampakis N, Xiao L, Elimova E, Shimodaira Y, Shiozaki H, Das P, Matamoros A, Sagebiel TL, Blum MA, Lee JH, Bhutani MS, Weston B, Mansfield PF, Minsky BD, Badgwell BD, Ajani JA. Course and predictors of postoperative outcomes in older patients with localized gastric adenocarcinoma treated preoperatively. J Clin Oncol 34(suppl 4S):abstr 132, 2016.
21. Crane CH, Tao R, Bhosale P, Javle MM, Shroff RT, Aloia TA, Kaseb AO, Koay EJ, Bishop AJ, Swanick CW, Hong TS, Das P, Krishnan S. Effect of ablative radiotherapy on survival in patients with inoperable intrahepatic cholangiocarcinoma: A dose response analysis. J Clin Oncol 34(suppl 4S):abstr 294, 2016.
22. Eng C, Adams RA, Kachnic LA, Das P, Ernst RD, Rodriguez-Bigas MA, Dupont E, Benson AB. Post-treatment surveillance in locally advanced squamous cell carcinoma (SCCA) of the anal canal: A global subspecialist survey. J Clin Oncol 34(suppl 4S):abstr 573, 2016.
23. Suh Y, Crane C, Krishnan S, Das P, Koay E, Beddar S. SU-E-J-33: Comparison Between Soft Tissue Alignment and Bony Alignment for Pancreatic Cancer Radiotherapy. Med Phys 42(6):3271, 2015. PMID: 26127430.
24. Suh Y, Hui C, Robertson D, Pan T, Das P, Crane C, Beddar S. SU-E-J-157: Comparison Between Internal Respiratory Signal and External Respiratory Signal in 4D CT. Med Phys 42(6):3301, 2015. PMID: 26127548.
25. Charalampakis N, Nogueras-Gonzalez GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Garris J, Matamoros A, Sagebiel TL, Das P, Estrella J, Badgwell BD, JAjani JA. Signet ring cell (SRC) histology of localized gastric adenocarcinoma (LGAC) to predict response to preoperative chemoradiation. J Clin Oncol 33S:Abstr 4067, 2015.
26. Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB. Long-Term outcomes of Hpv Vaccination In Prevention of Anal Cancer In older Hiv-Positive Men Who Have Sex With Men. Value Health 18(3):A206, 2015.
27. Deshmukh AA, Cantor SB, Chiao EY, Nyitray AG, Das P, Chhatwal J. Expansion of current HPV Vaccination guidelines to include Men who have Sex with Men who are 27 years or older – a value of information analysis. Value Health 18(3):A259, 2015.
28. Thaker N, Agarwal A, Pugh T, Mahmood U, Guzman A, Incalcaterra J, Bathala T, Kaplan R, Kudchadker R, Bingham J, Das P, Kuban D, Buchholz T, feeley T, Frank S. Quality Improvement in Prostate Brachytherapy Using Time Driven Activity Based Costing. Int J Radiat Oncol Biol Phys 93(3S):Abstr 3257, 2015.
29. Tao R, Krishnan S, Bhosale P, Javle M, Shroff R, Kaseb A, Jensen G, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH. Ablative Radiation Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma. Int J Radiat Oncol Biol Phys 93(3S):Abstr 256, 2015.
30. Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB. Adjuvant HPV vaccination in older HIV-positive men who have sex with men for prevention of anal cancer - Long-term clinical and economic benefits. Soc Med Dec Making Ann Mtg:Abstr PS2-5, 2015.
31. Deshmukh AA, Chhatwal J, Fenwisk E, Chiao EY, Nyitray AG, Das P, Cantor SB. The value of addition of HPV vaccination to anal precancerous lesion treatment in older MSM - Do we need further evidence?. Soc Med Dec Making Ann Mtg:Abstr 3H-4, 2015.
32. Swanick CW, Allen PK, Tao R, Olanrewaju AM, Sutton JR, Lin SH, Welsh J, Das P, Chang JY, Crane CH, Gomez DR. Incidence and Predictors of Chest Wall Toxicity after High-Dose Radiation Therapy in 15 Fractions. Int J Radiat Oncol Biol Phys 93(3S), 2015.
33. Voong K, Rashid A, Crane CH, Binsky BD, Krishnan S, Yao JC, Wolff RA, SKibber JM, Feig BW, Chang GJ, Das P. Radiation Therapy for High-Grade Neuroendocrine Carcinoma of the Rectm and Anal Canal. Int J Radiat Oncol Biol Phys 90(1S):Abstr 2455, 2014.
34. Thaker NG, Komaki R, Golden DW, Boehling NS, Gunther JR, Hillebrandt E, Mahajan A, Cox JD, Frank SJ, Woodward WA, Das P. Improving the Quality of Radiation Oncology Education Through an Innovative Medical Student Treatment Planning Curriculum. Int J Radiat Oncol Biol Phys 90(1S):Abstract 2992, 2014.
35. Walker GV, Johnson J, Edwards T, Gatilao RA, Hayden SE, Riley BA, Sittig DF, Gillin M, Ibbott G, Buchholz TA, Das P. Improving patient safety: Factors leading to radiation therapy events in a large academic institution. J Clin Oncol 31:suppl 31: Abstr 224, 2013.
36. Beddar S, Suh Y, Wen Z, Das P, Delclos ME, Krishnan S, Minsky BD, Crane CH. 4D and Multi-Phase Breath-Hold CT Imaging with Synchronized Intravenous Contrast Injection for Liver Tumor Delineation. IEEE Nuclear Science Symposium and Medical Imaging Conference:Abstract 2515, 2013.
37. Francis AM, Tzeng CD, Hyngstrom JR, Das P, Krishnan S, Minsky B, Crane C, Skibber JM, Chang GJ, Rodriguez-Bigas MA. Intraoperative Radiation Therapy (IORT) Improves Local Control after Microscopic Margin-Positive (R1) Radical Resection of Locally Advanced Colorectal Cancer. American College of Surgeons 2013 Clinical Congress, 2013.
38. Krishnan S, Ahmad M, Noguera Gonzalez G, Das P, Minsky B, Delclos M, Wolff R, Fleming J, Katz M, Crane C. Is CA19-9 Response Following Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer an Early Surrogate for Eventual Survival Outcomes?. Int J Radiat Oncol Biol Phys 87(2S):Abstr 2286, 2013.
39. Wattson DA, DiPiro PJ, Das P, Hodgson DC, Mauch PM. Low-Dose Chest CT for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost-Effectiveness Analysis. Int J Radiat Oncol Biol Phys 87(2S):Abstr 1083, 2013.
40. Tang Y, Crane CH, Eng C, Minsky BD, Delclos ME, Krishnan S, Malatek DL, Gould S, Das P. Quality of Life After Intensity Modulated Radiation Therapy (IMRT) for Anal Cancer. Int J Radiat Oncol Biol Phys 87(2S):Abstr 3051, 2013.
41. Skinner HD, Javle MM, Wolff RA, Clemons MV, Munsell MF, Delclos ME, Fleming JB, Das P, Crane CH, Krishnan S. Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer. J Clin Oncol 30 Suppl 4:Abstr 254, 2012.
42. Eng C, Rogers J, Chang GJ, You N, Das P, Rodriguez-Bigas MA, Ohinata A, Philips J, Abbruzzese JL, Wolff RA. Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. J Clin Oncol 30 suppl:Abstr 4060, 2012.
43. Mitchell MP, Abboud M, Crane CH, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience. J Clin Oncol 30 suppl 4:Abstr 661, 2012.
44. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Maru D, Munsell MF, Clemons MV, Kopetz S, Garrett CR, Shureiqi I, Krishnan S, Delclos ME, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial. J Clin Oncol 30 Suppl 4:Abstr 544, 2012.
45. Habra MA, Ejaz S, Feng L, Das P, Denis F, Grubbs EG, Phan AT, Waguespack S, Ayala-Ramirez M, Jimenez C, Vassilopoulou-Sellin R. Adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma: Retrospective cohort analysis. J Clin Oncol 30 Suppl:Abstr 4641, 2012.
46. Dalls N, Ghang GJ, Das P, Crane C, Feig B, Skibber J, Rodriguez-Bigas M, You Y. Locally-advanced rectal cancer in patients with inflammatory bowel disease: Is neoadjuvant chemoradiation safe?. Dis Colon Rectum 55(5):108 (Abstr P108), 2012.
47. Johnson JL, Dong L, Riley B, Kantor M, Kanke J, Hmar-Lagroun T, Gillin MT, Ibbott GS, Buchholz TA, Das P. Improvement in IMRT Quality Assurance Rates: A Quality Improvement Project at a Large Academic Institution. Int J Radiat Oncol Biol Phys 84(3S):S541, 2012.
48. Palmer M, Mok H, Ciura K, Georges R, Nguyen B, Crawford C, Beddar S, Zhu R, Crane C, Das P. Dose Reduction to Small Bowel and Other Relevant Structures in Rectal Carcinoma with Proton Therapy. Int J Radiat Oncol Biol Phys 84(3S):S846, 2012.
49. Sturgeon JD, Crane C, Krishnan S, Delclos M, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Int J Radiat Oncol Biol Phys 84(3S):S349, 2012.
50. Tzeng C, Hyngstrom JR, Beddar AS, Delclos ME, Crane CH, Krishnan S, Das P, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative Radiation Therapy for Locally Advanced Primary and Recurrent Colorectal Cancer: Ten-year Institutional Experience. Int J Radiat Oncol Biol Phys 84(3S):S345, 2012.
51. Park IJ, Hu C, Rodriguez-Bigas MA, You YN, Skibber JM, Eng C, Wolff RA, Das P, Crane CH, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer. J Clin Oncol 15S:234s, 2011.
52. Chang GJ, Park IJ, You YN, Hu C, Hamilton SR, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Nguyen ST, Rodriguez-Bigas MA, Skibber JM. Neoadjuvant treatment response and outcomes in locally advanced rectal cancer: Establishing oncologic benchmarks. J Clin Oncol 15S:232s, 2011.
53. Bhadkamkar NA, Kar SP, Weatherly J, Garrett CR, Vauthey J, Kaseb AO, Das P, Javle MM. The role of multimodality therapy in unresectable hilar cholangiocarcinoma. J Clin Oncol 29:e14626, 2011.
54. Patel CB, Kattepogu KM, Park IJ, Eng C, Delclos ME, Feig BW, Crane CH, Skibber JM, Das P, Rodriguez-Bigas MA, Krishnan S, Chang GJ. Impact of preoperative radiation dose escalation on pathologic outcomes and radiation toxicity in locally advanced rectal cancer (LARC): A matched-pair analysis. J Clin Oncol 29:e14036, 2011.
55. Mok H, Crane CH, Briere T, Beddar S, Delclos ME, Krishnan S, Das P. Intensity-modulated radiation therapy (IMRT): Differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. J Clin Oncol 29 (suppl 4):Abstr 586, 2011.
56. Eng C, Xing Y, You YN, Chang GJ, Das P, Phillips J, Wolff RA, Rodriguez-Bigas MA, Ohinata A, Crane CH. Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective. J Clin Oncol 29 (Suppl 4):Abstr 482, 2011.
57. Crane CH, Yordy JS, Varadhachary GR, Haque W, Wolff RA, Das P, Krishnan S, Fleming JB, Abbruzzese JL, Staerkel GA. Use of DPC-4 immunostaining of diagnostic cytology specimens to predict the pattern of tumor progression in locally advanced pancreatic cancer patients. J Clin Oncol 29 (Suppl 4):Abstr 209, 2011.
58. Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey J, Abdalla EK, Delclos ME, Das P, Crane CH, Krishnan S. Dose-escalated external beam radiotherapy in unresectable hepatocellular carcinoma. J Clin Oncol 29 (Suppl 4):Abstr 267, 2011.
59. Schoenfeld JD, Ng AK, Das P, Silver B, Mauch PM. Lung malignancies after Hodgkin lymphoma: Disease characteristics, detection methods and clinical outcome. Int J Radiat Oncol Biol Phys 81:S21, 2011.
60. Das P, Eng C. Rodriguez-Bigas MA, Chang GJ, Skibber JM, Maru DM, Munsell MF, Clemons MV, Krishnan S, Crane CH. Phase I trial of preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 81:S96, 2011.
61. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 81:S70, 2011.
62. Abboud MT, Crane C, Javle M, Kaseb A, Haque W, Delclos M, Krishnan S, Beddar S, Briere T, Das P. Risk factors for gastrointestinal bleeding in patients treated with radiation therapy for intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 81:S354, 2011.
63. You Y, Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Crane CH, Das P, Chang GJ. Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer. J Clin Oncol 28:Abstract 3647, 2010.
64. Crane CH, Varadhachary GR, Javle MM, Safran H, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Multi-institutional phase II trial of induction cetuximab, gemcitabine, and oxaliplatin, followed by radiotherapy with concurrent capecitabine, and cetuximab, for locally advanced pancreatic adenocarcinoma. Prog/Proc 2010 Gastrointestinal Cancers Symposium:Abstract 132, 2010.
65. Tsai C, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Delclos ME, Krishnan S, Das P. Number of lymph nodes examined and prognosis among pathologically node-negative patients after preoperative chemoradiation for rectal cancer. J Clin Oncol 28(15S):Abstract 3593, 2010.
66. Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Krishnan S, Delclos ME, Das P. Intensity Modulated Radiation Therapy (IMRT) with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. Proc ISGIO Annual Mtg 2010, 2010.
67. Mok H, Briere TM, Martel MK, Beddar S, Delclos ME, Krishnan S, Crane CH, Das P. Comparative Analysis of Volumetric Modulated Arc Therapy (VMAT) vs. Intensity Modulated Radiation Therapy (IMRT) for Radiotherapy of Anal Carcinoma. Int J Radiat Oncol Biol Phys 78:S830, 2010.
68. Mok H, Briere TM, Martel MK, Beddar S, Delclos ME, Krishnan S, Crane CH, Das P. Comparative Analysis of Volumetric Modulated Arc Therapy (VMAT) vs. Intensity Modulated Radiation Therapy (IMRT) for Radiotherapy of Anal Carcinoma. Int J Radiat Oncol Biol Phys 78:S830, 2010.
69. Tanaka M, Bedrosian I, Chang GJ, You YN, Das P, Li D, Rodriguez-Bigas MA, Skibber JM, Abbruzzese JL, Eng C. Correlation of single nuceotide polymorphisms (SNPs) of hypoxia-related genes with pathologic complete response following neoadjuvant chemoradiation for rectal cancer. J Clin Oncol 28:296S, 2010.
70. Crane CH, Varadhachary G, Javle M, Safran H, Krishnan S, Fleming J, Das P, Lee J, Abbruzzese JL, Wolff RA. Multi-institutional phase II trial of induction cetuximab, gemcitabine and oxaliplatin, followed by radiotherapy with concurrent capecitabine, and cetuximab, for locally advanced pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 78:S102, 2010.
71. Briere TM, Das P, Beddar S, Crane CH. Reproducibility of a vaginal dilator used for female anal cancer patients. Med Phys 37:3167, 2010.
72. Eng C, Chang GJ, Das P, Rodriguez-Bigas M, Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff RA, Crane CH. Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-RT) for squamous cell carcinoma of the anal canal. J Clin Oncol 27:196s, 2009.
73. Eng C, Chang GJ, Das P, Rodriguez-Bigas M,Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff RA, Crane CH. Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal. J Clin Oncol 27:Abstract 4116, 2009.
74. Haque W, Das P, Javle M, Kaseb A, Curley SA, Vauthey J-N, Abdalla EK, Delclos ME, Krishnan S, Crane CH. Radiation Therapy for Intrahepatic Cholangiocarcinoma. Proc ISGIO Annual Mtg 2009, 2009.
75. Herman MP, Kopetz S, Bhosale P, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Janjan NA, Krishnan S, Crane CH, Das P. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer. Proc ISGIO Annual Mtg 2008, 2008.
76. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity modulated radiation therapy (IMRT) for the treatment of squamous cell anal cancer with para-aortic nodal involvement. Prog/Proc 2008 Gastrointestinal Cancers Symposium:317, 2008.
77. Settle SH, Crane CH, Das P, Varadhachary G, Tamm EP, Javle M, Hodges JC, Krishnan S, Evans DB, Wolff RA. Novel use of focal high-dose IMRT for borderline resectable pancreatic cancer. Prog/Proc 2008 Gastrointestinal Cancers Symposium:170, 2008.
78. Pathak P, King BT, Ohinata A, Das P, Crane CH, Chase JL, Eng C. The treatment of metastatic squamous cell carcinoma of the anal canal: a single institution experience. Prog/Proc 2008 Gastrointestinal Cancers Symposium:244, 2008.
79. Myerson R, Garofalo M, el Naqa I, Abrams R, Bosch W, Das P, Gunderson L, Hong T, Kim J, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: An RTOG consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 72:S71, 2008.
80. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity modulated radiation therapy (IMRT) for the treatment of squamous cell anal cancer with para-aortic nodal involvement. Int J Radiat Oncol Biol Phys 72:S266, 2008.
81. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH. Long-term quality of life after chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 72:S104, 2008.
82. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II trial of neoadjuvant bevacizumab, capecitabine and radiotherapy for locally advanced rectal cancer. J Clin Oncol 26 (15S):200s, 2008.
83. Smith KD, Das P, Chang GJ, Feig BW, Skibber JM, Eng C, Krishnan S, Crane CH, Rodriguez-Bigas MA. Is the presence of acellular mucin in rectal cancer patients with a pathologic complete response to preoperative chemoradiation of prognostic significance?. J Clin Oncol 26 (15S):207s, 2008.
84. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Krishnan S, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Prog/Proc 2007 Gastrointestinal Cancers Symposium: 222:(#275), 2007.
85. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Krishnan S, Janjan NA, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Prog/Proc 2007 Gastrointestinal Cancers Symposium:289, 2007.
86. Krishnan S, Mendoza T, Lin EH, Vadhan-Raj S, Das P, Crane CH, Zhang Y, Wang XS, Cleeland CS, Janjan NA. Temporal patterns of fatigue predict pathological response in patients treated with preoperative chemoradiation therapy for rectal cancer. Prog/Proc 2007 Gastrointestinal Cancers Symposium:366, 2007.
87. Crane CH, Eng C, Chang GJ, Skibber JM, Das P, Wolff RA, Janjan NA, Krishnan S, Chang DZ, Hamilton SR, Rodriguez-Bigas MA, Feig B. Preliminary results of a phase II trial of concurrent bevacizumab with neoadjuvant capecitabine based chemoradiation for locally advanced rectal cancer. Proc Am Rad Soc: 4:(#SS-10), 2007.
88. Hundal M, Krishnan S, Mendoza T, Vadhan-Raj S, Das P, Crane C, Zhang Y, Wang XS, Cleeland C, Janjan N. Comparison of patient and physician-reported scores during preoperative chemoradiation for rectal cancer. Proc Am Rad Soc:(#SS-9), 2007.
89. Janjan NA, Wang XS, Mendoza T, Zhang Y, Das P, Crane C, Delclos M, Krishnan S, Cleeland C. Utility of the M.D. Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation in patients with gastrointestinal malignancies. J Clin Oncol 25(18S):350S (#6613), 2007.
90. Delclos M, Krishnan S, Mendoza T, Lin E, Vadhan-Raj S, Das P, Crane C, Zhang Y, Cleeland C, Janjan N. Baseline and temporal patterns of fatigue predict pathological response in patients treated with preoperative chemoradiation therapy for rectal cancer. J Clin Oncol 25(18S):626S (#14522), 2007.
91. Krishnan S, Mendoza T, Zhang Y, Wang XS, Das P, Delclos ME, Crane C, Cleeland C, Janjan N. Prevalence and temporal patterns of persistence of symptoms in 165 rectal cancer patients receiving preoperative chemoradiation therapy. J Clin Oncol 25(18S):713S (#19580), 2007.
92. Settle SH, Crane CH, Hodges JC, Das P, Varadhachary G, Tamm EP, Javle M, Fleming JB, Lee JE, Krishnan S, Evans D, Wolff RA. Novel use of focal high dose IMRT for borderline resectable pancreatic cancer. Proc ISGIO Annual Mtg 2007, 2007.
93. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Bedi M, Krishnan S, Janjan NA, Crane CH. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Rad Oncol Biol Phys 69:S277, 2007.
94. Gonzalez RJ, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Krishnan S, Das P, Crane C, Janjan N, Chang GJ. A twenty-year experience with adenocarcinoma of the anal canal. Annals Surg Oncol 14:54S, 2007.
95. Das P, Wolff RA, Abbruzzese JL, Krishnan S, Varadhachary GR, Xiong HQ, Evans DB, Vauthey JN, Baschnagel A, Crane CH. Concurrent capecitabine and upper abdominal radiation therapy is well-tolerated. Prog/Proc 2006 Gastrointestinal Cancers Symposium:Abstract 106, 2006.
96. Bhatia S, Krishnan S, Evans DB, Wolff R, Delclos ME, Das P, Abbruzzese JL, Janjan N, Pisters P, Crane CH. Carcinoma of the ampulla of Vater treated with combined modality therapy: Large single institution experience. Prog/Proc 2006 Gastrointestinal Cancers Symposium:Abstract 126, 2006.
97. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Janjan NA, Krishnan S, Crane CH. Predictors of tumor response and downstaging in patients treated with preoperative chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 66(Suppl):S167-168 (#1067), 2006.
98. Crane CH, Krishnan S, Rana V, Xiong HQ, Varadhachary G, Palla S, Evans DB, Das P, Ho L, Wolff RA. Does the addition of bevacizumab to chemoradiation prolong median survival in locally advanced pancreatic cancer patients?. Int J Radiat Oncol Biol Phys 66(Suppl):S173 (#1076), 2006.
99. Reed V, Krishnan S, Bhosale P, Das P, Janjan N, Delclos M, Lowy A, Mansfield P, Ajani J, Crane C. Patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 66(Suppl):S271 (#2109), 2006.
100. Yu T-K, Das P, Bhosale PR, Iyer RB, Delclos ME, Krishnan S, Janjan NA, Crane CH. Patterns of locoregional recurrence and their predictors in rectal cancer patients treated with surgery and chemoradiation. Accepted. Int J Radiat Oncol Biol Phys 63(Suppl):S12 (#20), 2005.
101. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Hoff PM, Eng C, Wolff RA, Krishnan S, Janjan NA, Crane CH. Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: a matched pair analysis. Accepted. Int J Radiat Oncol Biol Phys 63(Suppl):S164 (#1033), 2005.
102. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Hoff PM, Eng C, Janjan NA, Krishnan S, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis and overall survival in patients treated with chemoradiation and mesorectal excision for locally advanced rectal cancer. J Clin Oncol 23(16S):270S, 2005.
103. Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM. Decision analysis on computed tomography screening for lung cancer in Hodgkin's disease survivors. Proc Am Soc Clin Oncol 22:537, 2003.
104. Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM. Cost-effectiveness of computed tomography screening for lung cancer in Hodgkin's disease survivors. Int J Rad Oncol Biol Phys 57(Suppl):S213, 2003.
105. Das P, Smith RL, Schurman DJ. Shear stress induces the release of nitric oxide from articular chondrocytes. Trans Orthop Res Soc 20:354, 1995.
106. Smith RL, Das P, Collier MA. Biochemistry of repair cartilage following Holmium-YAG Laser treatment in the equine model. International Symposium on Biomedical Optics, 2395F:111, 1995.
107. Smith RL, Das P, Kajiyama GK, Schurman DJ. Staphylococcal septic arthritis: Effects of purified Staph factor on hexosaminidase and nitric oxide release from cartilage in vitro. Trans Orthop Res Soc 20:354, 1995.
108. Tsuchiya K, Das P, Mohtai M, Schurman DJ, Hoffman AR, Vu T, Smith RL. Differential regulation of IGF-I and IGF-II mRNA expression in response to shear stress in human articular cartilage chondrocytes. Trans Orthop Res Soc 20:480, 1995.

Book Chapters

1. Dasari A, Das P. Could upfront chemotherapy substitute preoperative radiochemotherapy?. In: Multidisciplinary Management of Rectal Cancer: Questions and Answers. 2. Springer, 2017.
2. Das P, Minsky BD. Radiation Therapy for Rectal Cancer. In: Rectal Cancer: Modern Approaches to Treatment. Springer, 2017.
3. Osborne E, Crane C, Das P. Anal Cancer: Background and Clinical Evidence. In: Radiation Therapy for Gastrointestinal Cancers. Springer, 2017.
4. Osborne E, Crane C, Das P. Anal Cancer: Radiation Therapy Planning. In: Radiation Therapy for Gastrointestinal Cancers. Springer, 2017.
5. Elimova E, Wadhwa R, Charalampakis N, Phan AT, Das P, Blum Murphy M. Gastric, Gastroesophageal Junction, and Esophageal Cancers. In: The MD Anderson Manual of Medical Oncology. 3. McGraw Hill Education, 2016.
6. Tsai CJ, Crane CH, Das P. Rectum. In: Practical Essentials of Intensity Modulated Radiation Therapy. 3. Wolters Kluwer Health/ Lippincott Williams & Wilkins, 349-355, 2014.
7. Das P, Shaaban AM. Gastric Carcinoma. In: Radiation Oncology: Imaging and Treatment. 1. Amirsys: Canada, 5:30-5:47, 2013.
8. Tan CH, Das P, Silberfein EJ, Rodriguez-Bigas M, Iyer RB. Colorectal Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier: Philadelphia, 267-286, 2012.
9. Bhosale P, Fleming J, Das P, Javle M, Lee JH. Cystic Pancreatic Lesions. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier: Philadelphia, 173-191, 2012.
10. Alberts SR, Citrin D, Rodriguez-Bigas M, Das P. Colon, rectal and anal cancers. In: Cancer Management: A Multidisciplinary Approach. 12. CMPMedica: Norwalk, CT, 329-363, 2010.
11. Janjan NA, Delclos ME, Crane CH, Krishnan S, Das P. The Colon and Rectum. In: Radiation Oncology. 9th. Elsevier: Philadelphia, 560-605, 2009.
12. Das P, Ludwig M, Janjan NA, Crane CH. The Anal Region. In: Radiation Oncology. 9th. Elsevier: Philadelphia, 606-623, 2009.
13. Krishnan S, Das P, Crane CH. The Liver and Biliary System. In: Radiation Oncology. 9th. Elsevier: Philadelphia, 534-559, 2009.
14. Janjan N, Mahajan A, Chang EL, McCutcheon I, Lin E, Das P, Krishnan S, Chow E. Prognosis in Spinal Cord Compression. In: Prognosis in Advanced Cancer. Oxford University Press, 329-344, 2008.
15. Das P, Rodriguez-Bigas MA, Hoff PM, Crane CH. Neoadjuvant and adjuvant therapy for rectal adenocarcinoma. In: Advanced Therapy in Surgical Oncology. BC Decker: Hamilton, Ontario, 308-315, 2008.
16. Janjan N, Krishnan S, Das P, Gould MS, Zampieri J, Crane C, Delclos M, Cleeland C, Lutz ST, Chow E. Palliative Radiation Therapy Techniques. In: Cancer Pain Management. McGraw Hill, 271-293, 2007.
17. Holliday EB, Das P. Gastrointestinal. In: Proton Therapy. Elsevier.

Books (edited and written)

1. Hong TS, Das P, Editors. Radiation Therapy for Gastrointestinal Cancers. Springer, 2017.

Letters to the Editor

1. Smith GL, Das P, Herman JM, Koay EJ, Koong AC, Grossberg A, Ludmir E. Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data. J Clin Oncol 36: 2565-2566, 2018.
2. Ajani JA, Blum MA, Estrella JS, Das P, Fournier KF. Gastric cancer: apples will always be apples. J Clin Oncol 30: 1017-1018, 2012.
3. Das P, Ha C, Cox JD. Radiotherapy and Hodgkin's lymphoma. J Clin Oncol 23: 8914-8915, 2005.